2023-11-14T15:10:19-06:00 2022-12-31 861065772 DELOITTE TAX LLP 695 TOWN CENTER DRIVE SUITE 1000 COSTA MESA CA 92626 990 2022-01-01 980593375 GAVI ALLIANCE GAVI 2024781050 CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 ASSIETOU DIOUF CHIEF FINANCIAL OFFICER 2024781050 2023-11-13 1 ASSIETOU DIOUF XXX-XX-XXXX 1 JOHN W SADOFF JR P00540589 7144367100 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z GAVI THE VACCINE ALLIANCE ASSIETOU DIOUF CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 4577260626 0 X GAVI.ORG X 2009 SZ TO SAVE LIVES & PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 45 45 15 73 0 0 16367570660 4419094530 0 0 72243278 98119459 -42699804 -136440227 16397114134 4380773762 8455743099 7206568867 0 0 63282276 70723075 0 0 28258391 62873137 77019732 8581898512 7354311674 7815215622 -2973537912 16258481147 11345377448 4899555355 2962819265 11358925792 8382558183 X TO SAVE LIVES AND PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 0 0 5575459058 5559626431 WITH ITS FIRST DELIVERIES COMMENCING IN JANUARY 2021, COVAX DELIVERED NEARLY 1.9 BILLION DOSES OF VACCINES TO PEOPLE IN 146 ECONOMIES BY THE END OF 2022. APPROXIMATELY 90% OF THESE DOSES HAVE GONE TO LOWER-INCOME ECONOMIES REPRESENTING THE FASTEST AND MOST COMPLEX GLOBAL DEPLOYMENT OF VACCINES EVER.FURTHER INFORMATION ON GAVI'S COVAX REPORT CAN BE FOUND IN ITS 2022 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS. 1715583877 1646942436 THE VACCINE GOAL: INTRODUCE AND SCALE UP VACCINESINCLUDING ROUTINE, PREVENTIVE CAMPAIGN AND COVID-19 VACCINATIONS, THE 57 GAVI-SUPPORTED COUNTRIES ADMINISTERED NEARLY THREE TIMES AS MANY VACCINE DOSES IN 2022 AS IN 2020.- 40 GAVI-SUPPORTED VACCINE INTRODUCTIONS AND PREVENTIVE CAMPAIGNS TOOK PLACE IN 2022 - IN ADDITION TO 40 OUTBREAK RESPONSE VACCINATION CAMPAIGNS SUPPORTED BY GAVI.- 4 KEY SUSTAINABLE DEVELOPMENT GOAL (SDG) VACCINES SAW AN INCREASE IN COVERAGE AMONG THE 57 GAVI-SUPPORTED COUNTRIES SINCE 2021.- 20 COUNTRIES ACCESSED EMERGENCY STOCKPILES FOR CHOLERA, EBOLA, MENINGOCOCCAL AND YELLOW FEVER VACCINES A TOTAL OF 33 TIMES IN 2022.- BREADTH OF PROTECTION WITH VACCINES IN THE GAVI PORTFOLIO IS NOW HIGHER IN GAVI-SUPPORTED COUNTRIES (56%) THAN IN THE REST OF THE WORLD (53%), AND IS UP 5 PERCENTAGE POINTS FROM 2021.THE EQUITY GOAL: STRENGTHEN HEALTH SYSTEMS TO INCREASE EQUITY IN IMMUNIZATIONIN GAVI 5.0/5.1, HEALTH SYSTEM STRENGTHENING (HSS) SUPPORT PRIORITISES EQUITY IN IMMUNISATION DELIVERY, TO REDUCE THE NUMBER OF ZERO-DOSE AND UNDER-IMMUNISED CHILDREN.- 2.6 MILLION MORE CHILDREN RECEIVED BASIC ROUTINE IMMUNISATIONS THROUGH GAVI-SUPPORTED HEALTH SYSTEMS IN 2022 THAN IN 2021.- 47 COUNTRIES HAVE INSTALLED MORE THAN 65,000 COLD CHAIN EQUIPMENT (CCE) UNITS PROCURED BY UNICEF SUPPLY DIVISION THROUGH GAVI'S COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) - NEARLY 13, 000 IN 2022 ALONE.- 17.2 MILLION IMMUNISATION SESSIONS WERE REPORTED IN GAVI-SUPPORTED COUNTRIES IN 2022.- 25 GAVI-SUPPORTED COUNTRIES INCREASED FIRST DOSE OF MEASLES-CONTAINING VACCINE (MCV1) COVERAGE FROM 2021 TO 2022, BUT MEASLES IMMUNITY GAPS REMAIN A SIGNIFICANT CONCERN.- IN 2022, DIPHTHERIA, PERTUSSIS AND TETANUS-CONTAINING VACCINE (DTP3) COVERAGE IN GAVI-SUPPORTED COUNTRIES REBOUNDED TO 81% AFTER TWO YEARS OF DECLINE (COMPARED TO THE 84% GLOBAL AVERAGE).THE SUSTAINABILITY GOAL: IMPROVE SUSTAINABILITY OF NATIONAL IMMUNIZATION PROGRAMMESTHE YEAR 2022 CONFIRMED THE ROBUSTNESS OF THE VACCINE ALLIANCE'S CO-FINANCING APPROACH AND THE STEADY FINANCIAL COMMITMENT OF COUNTRIES DESPITE RISING DEBT LEVELS AND THE WAR IN UKRAINE.- US $162 MILLION WAS CONTRIBUTED BY COUNTRIES TOWARDS THE CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2022 - THE HIGHEST AMOUNT YET AND A TESTAMENT TO COUNTRY OWNERSHIP AND THE LONG-TERM FINANCIAL SUSTAINABILITY OF GAVI-SUPPORTED VACCINES.- 54 VACCINE PROGRAMMES ORIGINALLY INTRODUCED WITH GAVI FUNDING ARE NOW SELF-FINANCED BY COUNTRIES AS OF 2022, UP FROM 40 IN 2018.- 100% OF COUNTRIES FULLY MET THEIR 2022 CO-FINANCING OBLIGATION - EXCEPT THREE WAIVERS FOR HUMANITARIAN CRISIS.- IN THE FACE OF FISCAL CHALLENGES, CLIMATE CHANGE, CONFLICT AND INSTABILITY, MOST GAVI-SUPPORTED COUNTRIES MAINTAINED OR INCREASED DOMESTIC RESOURCES FOR CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2022, BRINGING TO US$ 1.5 BILLION THEIR TOTAL CONTRIBUTION SINCE THE INTRODUCTION OF THE CO-FINANCING POLICY IN 2018.THE HEALTHY MARKETS GOAL: ENSURE HEALTHY MARKETS FOR VACCINES AND RELATED PRODUCTSGAVI'S MARKET SHAPING EFFORTS MAKE LIFE-SAVING VACCINES AND OTHER IMMUNISATION PRODUCTS MORE ACCESSIBLE AND AFFORDABLE FOR LOWER-INCOME COUNTRIES.- 10 MARKETS FOR VACCINES AND IMMUNISATION PRODUCTS EXHIBITED ACCEPTABLE LEVELS OF HEALTHY MARKET DYNAMICS IN 2022, MEETING THE TARGET FOR THE YEAR.- 9 INNOVATIVE PRODUCTS WERE WITHIN THE PIPELINE OF COMMERCIAL-SCALE MANUFACTURERS IN 2022, MEETING THE ALLIANCE TARGET OF 8 BY 2025 WELL AHEAD OF SCHEDULE.- 2 NEW PRODUCTS WITH IMPROVED CHARACTERISTICS WERE NEWLY OFFERED TO GAVI-SUPPORTED COUNTRIES IN 2022: A NEW LIQUID ROTAVIRUS VACCINE, IMPROVING EASE OF DELIVERY FOR HEALTH CARE WORKERS; AND A NEW PRESENTATION FOR YELLOW FEVER VACCINE, IMPROVING ITS COLD CHAIN FOOTPRINT.- THROUGH GAVI'S MARKET SHAPING EFFORTS, THE NUMBER OF MANUFACTURERS SUPPLYING PREQUALIFIED GAVI-SUPPORTED VACCINES HAS GROWN FROM 5 IN 2001 TO 19 IN 2022 (WITH MORE THAN HALF BASED IN LOW- AND MIDDLE-INCOME COUNTRIES).FURTHER INFORMATION ON GAVI'S PROGRESS TOWARDS ACHIEVING ITS STRATEGIC GOALS CAN BE FOUND IN ITS 2022 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS. 7291042935 1 1 0 1 0 0 0 0 0 0 1 1 0 1 1 1 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 X 61 0 1 15 1 0 1 SZ NO EI LU 0 0 0 0 0 0 0 0 0 0 X 45 45 0 0 1 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X ASSIETOU DIOUF 2024781050 CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 X JOSE MANUEL BARROSO CHAIR 2.00 0.00 X 0 0 0 SARAH GOULDING VICE CHAIR 2.00 0.00 X 0 0 0 OMAR ABDI BOARD MEMBER 2.00 0.00 X 0 0 0 KWAKU AGYEMAN-MANU BOARD MEMBER 2.00 0.00 X 0 0 0 TAKESHI AKAHORI ALT BOARD MEMB FROM 02/22 - 06/22, THEN BOARD MEMB. 2.00 0.00 X 0 0 0 BETH ARTHY BOARD MEMBER 2.00 0.00 X 0 0 0 ANAHIT AVANYESAN BOARD MEMBER 2.00 0.00 X 0 0 0 AFSANEH BESCHLOSS BOARD MEMBER 2.00 0.00 X 0 0 0 BERNHARD BRAUNE BOARD MEMBER 2.00 0.00 X 0 0 0 ROGER CONNOR BOARD MEMBER - UNTIL 11/2022 2.00 0.00 X 0 0 0 MAHIMA DATLA BOARD MEMBER 2.00 0.00 X 0 0 0 MARGARET PEGGY HAMBURG BOARD MEMBER 2.00 0.00 X 0 0 0 AAMER IKRAM BOARD MEMBER - FROM 06/2022 2.00 0.00 X 0 0 0 ZSUZANNA JAKAB BOARD MEMBER 2.00 0.00 X 0 0 0 ROBERT LUCIEN KARGOUGOU BOARD MEMBER - FROM 05/2022 2.00 0.00 X 0 0 0 NAGUIB KHERAJ BOARD MEMBER 2.00 0.00 X 0 0 0 MANSUKH MANDAVIYA BOARD MEMBER 2.00 0.00 X 0 0 0 VIOLAINE MITCHELL BOARD MEMBER 2.00 0.00 X 0 0 0 MARTA NUNES BOARD MEMBER 2.00 0.00 X 0 0 0 MIN CHARLEMAGNE OUEDRAOGO BOARD MEMBER - FROM 01/22 - 04/22 2.00 0.00 X 0 0 0 HELEN REES BOARD MEMBER - UNTIL 06/2022 2.00 0.00 X 0 0 0 TERESA RESSEL BOARD MEMBER 2.00 0.00 X 0 0 0 JOHN ARNE ROTTINGEN BOARD MEMBER 2.00 0.00 X 0 0 0 ANNE SCHUCHAT BOARD MEMBER - FROM 01/2022 2.00 0.00 X 0 0 0 AWA MARIE COLL SECK BOARD MEMBER 2.00 0.00 X 0 0 0 DEENA SHIFF BOARD MEMBER - FROM 07/2022 2.00 0.00 X 0 0 0 FAISAL SULTAN BOARD MEMBER - UNTIL 06/2022 2.00 0.00 X 0 0 0 JUAN PABLO URIBE BOARD MEMBER 2.00 0.00 X 0 0 0 RAFAEL VILASANJUAN BOARD MEMBER - FROM 01/2022 2.00 0.00 X 0 0 0 YIBING WU BOARD MEMBER 2.00 0.00 X 0 0 0 EDNA YOLANI BATRES ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 MEGAN CAIN BOARD MEMB - UNTIL 05/22, ALT. BOARD MEMB. UNTIL 09/22 2.00 0.00 X 0 0 0 WON DO-YEON ALTERNATE BOARD MEMBER - FROM 02/22 2.00 0.00 X 0 0 0 SUSAN ELDEN ALTERNATE BOARD MEMBER - UNTIL 06/22 2.00 0.00 X 0 0 0 GABRIELLA FESUS ALTERNATE BOARD MEMBER - FROM 03/22 2.00 0.00 X 0 0 0 ATUL GAWANDE ALTERNATE BOARD MEMBER - FROM 02/22 2.00 0.00 X 0 0 0 MOHAMED JAMA ALTERNATE BOARD MEMBER - FROM 01/22 2.00 0.00 X 0 0 0 JORIS JURRIENS ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 ETLEVA KADILLI ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 JEREMY KONYNDYK ALTERNATE BOARD MEMBER - UNTIL 02/22 2.00 0.00 X 0 0 0 SILVIA LUTUCUTA ALTERNATE BOARD MEMBER - FROM 01/22 2.00 0.00 X 0 0 0 BVUDZAI MAGADZIRE ALTERNATE BOARD MEMBER - FROM 01/22 2.00 0.00 X 0 0 0 FRANCESCA MANNO ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 ALAA MURABIT ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 KATE O'BRIEN ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 SAAD OMER ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 KEIICHI ONO ALTERNATE BOARD MEMBER - UNTIL 02/22 2.00 0.00 X 0 0 0 JAN PAEHLER ALT. BOARD MEMBER - FROM 01/22-03/22 2.00 0.00 X 0 0 0 BOUNFENG PHOUMMALAYSITH ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 MICHAEL KENT RANSON ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 XIANG SHU ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 JOSHUA TABAH ALTERNATE BOARD MEMBER - FROM 09/22 2.00 0.00 X 0 0 0 LIA TADESSE ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 AN VERMEESCH ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 DR SETH BERKLEY CHIEF EXECUTIVE OFFICER 47.50 2.50 X 724451 0 115010 BRENDA KILLEN DIRECTOR, GOVERNANCE 42.50 7.50 X 256994 0 56576 ASSIETOU DIOUF CHIEF FINANCIAL OFFICER 47.50 2.50 X 229109 0 69631 ANURADHA GUPTA DEPUTY CHIEF EXECUTIVE OFFICER - UNTIL 09/22 48.50 1.50 X 313647 0 62228 PASCAL BAROLLIER MANAGING DIR, PUBLIC ENGAGEMENT & IS 50.00 0.00 X 263911 0 84098 MARIE-ANGE SARAKA-YAO MNG DIR, RESOURCE MOBL./PARTNERSHIPS 50.00 0.00 X 275687 0 64949 THABANI MAPHOSA MANAGING DIR, COUNTRY PROGRAMMES 50.00 0.00 X 246074 0 64838 AURELIA NGUYEN MNG DIR OFFICE OF THE COVAX FACILITY - UNTIL 07/22 50.00 0.00 X 240121 0 59625 DERRICK SIM ACTING MD OFFICE OF COVAX FACILITY - FROM 07/22 50.00 0.00 X 208021 0 64208 DAVID MARLOW CHIEF OPERATING OFFICER - FROM 07/22 48.50 1.50 X 164348 0 36952 HANNAH BURRIS CHIEF OF STAFF 50.00 0.00 X 320426 0 53493 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 50.00 0.00 X 274334 0 61972 ANDREW MENDS DIRECTOR OPERATIONS 50.00 0.00 X 273114 0 61646 PAOLO SISON DIRECTOR INNOVATIVE FINANCE 50.00 0.00 X 264535 0 64901 JEANNE SHEN CHIEF INVESTMENT OFFICER 50.00 0.00 X 259709 0 56067 4314481 0 976194 299 0 1 0 HELVETIC PAYROLL SA RUE DU LAUSANNE 44 GENEVA SZ 1201 TEMPORARY STAFFING 5932398 TECH MAHINDRA LIMITED OFF KARVE ROAD PUNE IN 411004 IT SERVICES 5757350 THE BOSTON CONSULTING GROUP AND CIE BLEICHERWEG 62 ZURICH SZ 8002 CONSULTING SERVICES 4193730 MICHAEL PAGE INTERNATIONAL SUISSE QUAI DE LA POSTE 12 GENEVA SZ 1204 TEMPORARY STAFFING 2253066 MCKINSEY AND COMPANY INC BLEICHERWEG 62 ZURICH SZ 8002 CONSULTING SERVICES 1138433 210 490000000 3830958109 98136421 1308272506 4419094530 93043467 93043467 201562856 196479485 7379 5083371 -7379 5075992 5075992 TAX REFUND 900099 6740 6740 OTHER INCOME 900099 6 6 FC TRANSLATION ADJ. 900099 -136446973 -136446973 -136440227 4380773762 0 0 -38320768 100264496 100264496 7106304371 7106304371 3600478 2346792 566353 687333 46281143 30135409 7817843 8327891 9711196 6323382 1639481 1748333 10033484 6533482 1689589 1810413 1096774 714194 184511 198069 1812059 1812059 985448 985448 277200 277200 3177807 3177807 46516875 25520201 9240352 11756322 558806 175012 16521 367273 4785240 2478768 1695786 610686 4037871 2628715 776181 632975 4785626 2478967 1695923 610736 3526231 2603117 371712 551402 2554156 725640 1249285 579231 862979 447026 305821 110132 2096829 1086163 743071 267595 TRAINING & RECRUITMENT 1042605 1042605 7354311674 7291042935 35010348 28258391 X 33492150 21831036 6392239 5268875 1264065924 19778047 5786704150 6886494482 3099817956 1961055637 4263399020 611549794 9116296 6904470 2347839 2211826 1241567725 1028190736 600578533 836096926 16258481147 11345377448 57988019 50376809 59080922 36793003 416512779 873650200 500280000 0 3865693635 2001999253 4899555355 2962819265 X 5218171172 2172353383 6140754620 6210204800 11358925792 8382558183 16258481147 11345377448 X -2973537912 -117665966 114836269 X 0 1 X 1 0 X 596158662 800186577 2433703395 16367570660 4419094530 24616713824 596158662 800186577 2433703395 16367570660 4419094530 24616713824 3291975524 21324738300 29223123 31105860 16200090 11257940 93043467 180830480 430236 274962 27180 186856 6746 925980 24798470284 0.85990 0.84860 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2018 AMOUNT: $ 295,261. 2019 AMOUNT: $ 266,165. 2020 AMOUNT: $ 27,180. 2021 AMOUNT: $ 186,856. 2022 AMOUNT: $ 6. PARKING FEES - 2018 AMOUNT: $ 134,975. 2019 AMOUNT: $ 8,797. TAX REFUND - 2022 AMOUNT: $ 6,740. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 277200 0 0 277200 0 PART II-B, LINE 1: FEES WERE PAID FOR: 1. PRESENTATION AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF OF THE HOUSE AND SENATE COMMITTEES ON APPROPRIATIONS, AND ANY OTHER COMMITTEES NEEDED, TO REQUEST SUPPORT FOR THE GAVI ALLIANCE; AND 2. SUPPORT AND GUIDANCE TO GAVI ALLIANCE IN POSITIONING THE ORGANIZATION WITH THE ADMINISTRATION, AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF ON VARIOUS COMMITTEES. 1334587 608360 726227 1203012 593729 609283 6578697 5702381 876316 2211826 LIMITED LIABILITY COMPANIES AND LIMITED PARTNERSHIPS 702448362 F REGISTERED INVESTMENT COMPANIES 325742374 F 1028190736 ACCOUNTS RECEIVABLE 606738254 CURRENCY FORWARD CONTRACTS 144407671 DUE FROM GAVI AFFILIATES 57395970 OPERATING LEASE RIGHT OF USE ASSET 16433541 RECEIVABLE ON COVAX FACILITY ARRANGEMENTS 5675300 OTHER ASSETS 5446190 836096926 PROCUREMENT ACCOUNTS PAYABLE 957016086 PAYABLE ON COVAX FACILITY ARRANGEMENTS 854315841 REFUNDABLE ADVANCE 161419853 OPERATING LEASE OBLIGATION 18859201 FOREIGN CURRENCY FORWARD CONTRACTS PAYABLE 10388272 2001999253 X PART X, LINE 2: GAVI IS EXEMPT FROM INCOME TAXES IN EACH OF THE JURISDICTIONS IN WHICH IT HAS OPERATIONS. US GAAP REQUIRES THAT FINANCIAL STATEMENTS REFLECT THE EXPECTED FUTURE TAX CONSEQUENCES OF UNCERTAIN TAX POSITIONS THAT AN ENTITY HAS TAKEN OR EXPECTS TO TAKE ON A TAX RETURN, PRESUMING THE TAX AUTHORITIES' FULL KNOWLEDGE OF THE POSITION AND ALL RELEVANT FACTS. US GAAP ALSO REQUIRES THAT AN ENTITY RECOGNISES THE BENEFIT OF TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT THAT THE PROVISION WILL BE SUSTAINABLE BASED ON THE MERITS OF THE POSITION. GAVI PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEARS ENDED 31 DECEMBER 2022 AND 2021 AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR WHICH MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. AS OF 31 DECEMBER 2022, THE STATUTES OF LIMITATIONS FOR TAX YEARS 2019 THROUGH 2021 REMAIN OPEN WITH THE UNITED STATES FEDERAL JURISDICTION OR THE VARIOUS STATES AND LOCAL JURISDICTIONS IN WHICH GAVI FILES TAX RETURNS. IT IS GAVI'S POLICY TO RECOGNISE INTEREST OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IF ANY, IN INCOME TAX EXPENSE. AS OF 31 DECEMBER 2022 AND 2021, GAVI HAD NO ACCRUED INTEREST OR PENALTIES. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 124713349 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 2737860769 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 2108672042 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 320165479 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 54822870 RUSSIA AND NEIGHBORING STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 163146115 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 53717264 SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 7085011 VARIOUS REGIONS 0 0 GRANTS TO RECIPIENTS LOCATED IN VARIOUS REGIONS 1536121472 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 INVESTMENTS 5262758615 EUROPE (INCLUDING ICELAND & GREENLAND) 1 360 PROGRAM SERVICES COUNTRY PROGRAMMES MGMT. & OVERSIGHT, POLICY & PERFORMANCE, AND OPERATIONS 84474068 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 FUNDRAISING 28258391 0 0 1 360 1 360 5570182899 6911612546 12481795445 SOUTH ASIA COUNTRY PROGRAMMES 26708499 BOARD APPROVAL/WIRE TRANSFER 89738929 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 143171 COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 15869780 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 0 589226 VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 13007882 BOARD APPROVAL/WIRE TRANSFER 699716871 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 807066 BOARD APPROVAL/WIRE TRANSFER 21545644 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SOUTH ASIA COUNTRY PROGRAMMES 0 3529856 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SOUTH AMERICA COUNTRY PROGRAMMES 0 6110714 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 10296277 BOARD APPROVAL/WIRE TRANSFER 42741049 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5060399 BOARD APPROVAL/WIRE TRANSFER 7232479 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 1291446 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 2095516 BOARD APPROVAL/WIRE TRANSFER 18739086 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5623572 BOARD APPROVAL/WIRE TRANSFER 21859711 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1432598 BOARD APPROVAL/WIRE TRANSFER 18192547 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 10991589 BOARD APPROVAL/WIRE TRANSFER 62817471 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 560355 BOARD APPROVAL/WIRE TRANSFER 1883349 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2849717 BOARD APPROVAL/WIRE TRANSFER 209949 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 55754193 BOARD APPROVAL/WIRE TRANSFER 184597054 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4261314 BOARD APPROVAL/WIRE TRANSFER 53397589 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 116789 VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 1561936 BOARD APPROVAL/WIRE TRANSFER 2118201 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 63778814 COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 3145191 COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3709563 BOARD APPROVAL/WIRE TRANSFER 5966742 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 1009729 COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17790873 BOARD APPROVAL/WIRE TRANSFER 280573391 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 95887 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 548243 BOARD APPROVAL/WIRE TRANSFER 3256395 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12324706 BOARD APPROVAL/WIRE TRANSFER 55130469 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 63608 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5674814 BOARD APPROVAL/WIRE TRANSFER 34713421 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 312418 BOARD APPROVAL/WIRE TRANSFER 2926415 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SOUTH AMERICA COUNTRY PROGRAMMES 0 974298 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 2299638 BOARD APPROVAL/WIRE TRANSFER 12102545 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 23590614 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SOUTH ASIA COUNTRY PROGRAMMES 15378477 BOARD APPROVAL/WIRE TRANSFER 691035768 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 4610631 BOARD APPROVAL/WIRE TRANSFER 110251037 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 80472 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12700088 BOARD APPROVAL/WIRE TRANSFER 50613979 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 613733 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 1617453 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) COUNTRY PROGRAMMES 0 5032699 COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 3839893 BOARD APPROVAL/WIRE TRANSFER 4306308 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, COVAX COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 2285958 BOARD APPROVAL/WIRE TRANSFER 2013264 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 602804 BOARD APPROVAL/WIRE TRANSFER 3718032 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2626760 BOARD APPROVAL/WIRE TRANSFER 23415452 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3700918 BOARD APPROVAL/WIRE TRANSFER 33335913 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 14840575 BOARD APPROVAL/WIRE TRANSFER 67176150 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 3583045 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 8169814 BOARD APPROVAL/WIRE TRANSFER 27841508 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4365566 BOARD APPROVAL/WIRE TRANSFER 12603844 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 0 1953183 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 2076365 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17117295 BOARD APPROVAL/WIRE TRANSFER 102884229 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 653040 COVAX COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 8669 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 12130355 VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 7842167 BOARD APPROVAL/WIRE TRANSFER 120527851 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 1018790 BOARD APPROVAL/WIRE TRANSFER 11215479 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 14515363 BOARD APPROVAL/WIRE TRANSFER 72234831 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 63146234 BOARD APPROVAL/WIRE TRANSFER 160459099 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SOUTH ASIA COUNTRY PROGRAMMES 24354882 BOARD APPROVAL/WIRE TRANSFER 414045995 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 4228091 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 5632487 BOARD APPROVAL/WIRE TRANSFER 4349863 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 30272239 COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2485952 BOARD APPROVAL/WIRE TRANSFER 33410168 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 0 164609 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 219297 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 140000 BOARD APPROVAL/WIRE TRANSFER 117309 COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1881205 BOARD APPROVAL/WIRE TRANSFER 18501550 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV EUROPE (INCLUDING ICELAND AND GREENLAND) COUNTRY PROGRAMMES 0 6230 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2523089 BOARD APPROVAL/WIRE TRANSFER 31638818 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 64223 BOARD APPROVAL/WIRE TRANSFER 1754947 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 19427385 BOARD APPROVAL/WIRE TRANSFER 54798703 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SOUTH ASIA COUNTRY PROGRAMMES 0 216369 VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 7193315 BOARD APPROVAL/WIRE TRANSFER 26339003 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 29484952 BOARD APPROVAL/WIRE TRANSFER 176113052 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 15854762 BOARD APPROVAL/WIRE TRANSFER 11599156 VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 3540545 BOARD APPROVAL/WIRE TRANSFER 23245328 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 15156368 BOARD APPROVAL/WIRE TRANSFER 288257069 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 1455297 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2918883 BOARD APPROVAL/WIRE TRANSFER 9472162 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 7265404 COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 62319 COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 22884517 BOARD APPROVAL/WIRE TRANSFER 139959564 VACCINE SUPPORT, YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 0 257014 COVAX COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 5792369 BOARD APPROVAL/WIRE TRANSFER 119879264 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 341153 COVAX VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 2275303 BOARD APPROVAL/WIRE TRANSFER 113330331 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 3723250 BOARD APPROVAL/WIRE TRANSFER 19322839 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3497070 BOARD APPROVAL/WIRE TRANSFER 101907289 VACCINE SUPPORT, COVAX VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1044357 BOARD APPROVAL/WIRE TRANSFER 12998357 VACCINE SUPPORT, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV VARIOUS REGIONS COUNTRY PROGRAMMES 1297075440 BOARD APPROVAL/WIRE TRANSFER 239046032 YELLOW FEVER DIAGNOSTICS, COVAX VACCINE SUPPORT, COVAX COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC WORK PLAN 2390283 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 38700 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 22479 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 258491 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 449848 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 285820 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 63463 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 261869 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 161164 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 58283 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 3097535 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 304390 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 667500 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1751325 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 16835 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 819436 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 449368 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 442833 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 674892 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 500000 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 1530032 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 926066 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 46878 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 16500 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 305840 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 104568 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 172474 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1166351 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 78990 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 326697 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 281572 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 474791 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 42772 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 230250 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1676155 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 172010 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 34565 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 29080 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 269397 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 446061 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 4597534 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 122951 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 126324 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 341632 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 95498 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 1000000 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 1102650 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 51065 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 103202 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 148580 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 885473 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 41401 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 147210 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 36515471 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 236406 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 180279 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND AND GREENLAND) WORK PLAN 66437463 BOARD APPROVAL/WIRE TRANSFER 0 MIDDLE EAST AND NORTH AFRICA WORK PLAN 14300 BOARD APPROVAL/WIRE TRANSFER 0 23 127 1 0 0 0 0 1 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT SUPPORT AND PROTECTS AGAINST CORRUPTION AND FRAUD THROUGH COLLABORATION WITH PARTNERS, THROUGH THE MAINTENANCE AND IMPLEMENTATION OF ROBUST POLICIES AND PROCEDURES, GRANT TERMS AND CONDITIONS, AND AN AUDIT AND INVESTIGATIONS FUNCTION. POLICIES AND PROCEDURES: ALL APPLICATIONS FOR NEW SUPPORT, AND REQUESTS FOR CONTINUED SUPPORT, REQUIRE AN ENDORSEMENT AND SIGNATURES FROM A NATIONAL COORDINATION BODY WHICH IN THE CASE OF NEW VACCINES SUPPORT, IS THE INTER-AGENCY COORDINATION COMMITTEE (ICC). THE ICC INCLUDES ON ITS MEMBERSHIP, IN ADDITION TO HIGH LEVEL REPRESENTATION OF THE GOVERNMENT OF GAVI COUNTRIES, GAVI PARTNERS SUCH AS THE WORLD HEALTH ORGANIZATION, UNICEF, NONGOVERNMENTAL ORGANIZATIONS AND DONOR GOVERNMENTS. IN THE CASE OF CASH SUPPORT FOR HEALTH SYSTEM STRENGTHENING, ENDORSEMENT IS REQUIRED FROM THE HEALTH SECTOR COORDINATION COMMITTEE (HSCC) OR OTHER SIMILAR INTER-AGENCY COMMITTEE WHICH ALSO INCLUDES THE GOVERNMENT, BILATERAL, MULTILATERAL AGENCIES AND CIVIL SOCIETY REPRESENTATIVES. IN ADDITION, THE APPLICATIONS SUBMITTED MUST INCLUDE THE SIGNATURES OF THE MINISTER OF HEALTH AND THE MINISTER OF FINANCE. THE GAVI NEW APPLICATIONS GUIDELINES PROVIDE DETAILS ON GAVI SUPPORT, INCLUDING GENERAL PRINCIPLES AND THE PROCESS FOR APPLYING AND MONITORING ACTIVITIES. A PARTNERSHIP FRAMEWORK AGREEMENT IS ENTERED INTO BETWEEN GAVI AND COUNTRIES THAT SETS OUT THE TERMS AND CONDITIONS GOVERNING GAVI SUPPORT. THE MAIN TOOLS/APPROACHES USED BY GAVI TO MONITOR THE USE OF GAVI SUPPORT ARE THE FOLLOWING: (1) IN-COUNTRY COORDINATING AND SUPERVISORY COMMITTEES (ICC AND HSCC); (2) ROUTINE MONITORING MISSIONS IN-COUNTRY, LED BY SENIOR COUNTRY MANAGERS, WORKING WITH PARTNERS AND IN-COUNTRY COUNTERPARTS AS WELL AS FORMAL ANNUAL JOINT APPRAISALS THAT REVIEW PERFORMANCE OF ALL GRANTS IN-COUNTRY; (3) FOR CASH GRANTS - RISK-BASED PROGRAMME AUDITS AND PERIODIC EXTERNAL AUDITS ON TOP OF ROUTINE FINANCIAL REPORTING REQUIREMENTS; (4) THE PROGRAMME CAPACITY ASSESSMENTS THAT INDEPENDENTLY ASSESS FINANCIAL MANAGEMENT ARRANGEMENTS AND PROGRAMMATIC/MANAGEMENT CAPACITIES IN-COUNTRY AS WELL AS INVESTIGATIONS IN CASES OF SUSPECTED OR ACTUAL MISUSE OF FUNDS; AND (5) ROUTINE REVIEW BY THE SECRETARIAT OF QUANTITATIVE AND QUALITATIVE INFORMATION PROVIDED THROUGH THE MONITORING AND PERFORMACE MANAGEMENT SYSTEM AND JOINT APPRAISALS, AS WELL AS ANY ADDITIONAL REPORTS/EVALUATIONS/SURVEYS/ASSESSMENTS SUBMITTED TO GAVI BY RECIPIENT GOVERNMENTS. COLLABORATION WITH PARTNERS: GAVI MAINTAINS FORMAL AND INFORMAL CONTACT WITH THE PARTNERS (THE BILL & MELINDA GATES FOUNDATION, UNICEF, WHO, THE WORLD BANK GROUP, CIVIL SOCIETY ORGANIZATIONS, DEVELOPING COUNTRY GOVERNMENTS, DEVELOPING COUNTRY PHARMACEUTICAL INDUSTRY, INDUSTRIALISED COUNTRY GOVERNMENTS, INDUSTRIALISED COUNTRY PHARMACEUTICAL INDUSTRY, RESEARCH AND TECHNICAL HEALTH INSTITUTES) AT VARIOUS LEVELS TO HELP ENSURE THAT RELEVANT INFORMATION ABOUT SUSPECTED AND ACTUAL CASES OF CORRUPTION AND MISUSE OF FUNDS IS SHARED ON A TIMELY BASIS. GAVI ENGAGES UNICEF, A KEY PARTNER IN GAVI, THE VACCINE ALLIANCE, FOR THE PURCHASE AND DELIVERY OF VACCINES. UNICEF MANAGES VACCINE LOGISTICS AND DELIVERY IN ACCORDANCE WITH ITS INTERNAL CONTROLS AND INTERNAL AND EXTERNAL AUDITS AS MANDATED BY ITS MEMBER STATES. GAVI AND UNICEF HAVE ENTERED INTO VARIOUS AGREEMENTS WHICH PROVIDE FOR CONFIRMATIONS, ASSURANCES AND INFORMATION REGARDING UNICEF ACTIVITIES CARRIED OUT ON BEHALF OF THE ALLIANCE. AUDIT AND INVESTIGATIONS: THE PRIMARY RESPONSIBILITY OF THE AUDIT AND INVESTIGATIONS FUNCTION IS ASSIST THE MANAGEMENT AND STAKEHOLDERS OF GAVI IN ACCOMPLISHING ITS OBJECTIVES AND TO ENHANCE AND PROTECT ORGANISATIONAL VALUE BY PROVIDING RISK-BASED AND OBJECTIVE ASSURANCE, AND INSIGHT, AND ASSESS PROBITY. THE WORK OF AUDIT AND INVESTIGATIONS EXTENDS NOT ONLY TO THE SECRETARIAT, BUT ALSO TO GAVI-SUPPORTED PROGRAMMES IN-COUNTRY INCLUDING THE FACILITY. AUDIT AND INVESTIGATIONS IS LED BY A MANAGING DIRECTOR WHO REPORTS TO THE BOARD, THROUGH ROUTINE REPORTING TO THE AUDIT AND FINANCE COMMITTEE, AND TO THE CHIEF EXECUTIVE OFFICER. THE TRANSPARENCY AND ACCOUNTABILITY POLICY (TAP): THROUGH TAP, GAVI IS ABLE TO ENSURE THAT ALL GAVI SUPPORT AT COUNTRY LEVEL IS MANAGED IN A TRANSPARENT AND ACCOUNTABLE MANNER THROUGH SYSTEMS THAT INCLUDE APPROPRIATE OVERSIGHT MECHANISMS, AND THAT THE SUPPORT IS USED ACCORDING TO THE PROGRAMME OBJECTIVES AS OUTLINED IN INDIVIDUAL COUNTRY AGREEMENTS. THE POLICY GOVERNS THE TRANSPARENCY AND ACCOUNTABILITY ASPECTS OF GAVI SUPPORT PROVIDED IN THE FORM OF CASH, VACCINES AND VACCINE DEVICES AT COUNTRY LEVEL. THE PRINCIPLES GOVERNING TAP INCLUDE: RESPECT AID EFFECTIVENESS PRINCIPLES; FOCUS ON PREVENTION; RELATE MONITORING TO RISK; PROMOTE FLEXIBILITY AND COUNTRY OWNERSHIP; PROMOTE MUTUAL ACCOUNTABILITY; AND STRENGTHEN COUNTRY SYSTEMS. TAP AIMS TO RETAIN FLEXIBLE AND NON-PERSPECTIVE APPROACH TO ALLOW FOR DIFFERENCES IN COUNTRY CONTEXT AND ENHANCES CONTINUED EFFORTS BY GAVI TO SUPPORT SUSTAINABLE DEVELOPMENT OF COUNTRY CAPACITY. PART I, LINE 3: THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. PART III ACCOUNTING METHOD: PART I, LINE 3, COLUMN (D) RECIPIENTS REFER TO COUNTRIES OR PARTNERS LOCATED IN THE REGION. PART II, LINE 1 THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. 1 ALBERT B SABIN VACCINE INSTITUTE 2000 PENNSYLVANIA AVE NW SUITE 7100 WASHINGTON DC 20006 061389829 501(C)(3) 389614 0 PARTNER SUPPORT BULL CITY LEARNING INC 102 CITY HALL PLAZA 200 DURHAM NC 27701 285356 0 PARTNER SUPPORT CDC 1600 CLIFTON ROAD ATLANTA GA 30303 586051157 CDC 140000 0 PARTNER SUPPORT CDC FOUNDATION 600 PEACHTREE ST NE SUITE 1000 ATLANTA GA 30303 582106707 501(C)(3) 2908190 0 PARTNER SUPPORT CLINTON HEALTH ACCESS INITIATIVE 383 DORCHESTER AVENUE SUITE 400 BOSTON MA 02127 271414646 501(C)(3) 2690365 0 PARTNER SUPPORT FAMILY HEALTH INTERNATIONAL 359 BLACKWELL STREET SUITE 200 DURHAM NC 27701 237413005 501(C)(3) 190504 0 PARTNER SUPPORT HARVARD - PRESIDENT AND FELLOWS OF HARVARD COLLEGE 1033 MASSACHUSSETS AVENUE CAMBRIDGE MA 02138 042103580 501(C)(3) 112734 0 PARTNER SUPPORT JHPIEGO 1615 THAMES STREET BALTIMORE MD 21231 237424444 501(C)(3) 842696 0 PARTNER SUPPORT JOHNS HOPKINS UNIVERSITY 1101 E33RD STREET SUITE D200 BALTIMORE MD 21218 520595110 501(C)(3) 1831251 0 PARTNER SUPPORT JSI RESEARCH & TRAINING INSTITUTE INC 2733 CRYSTAL DRIVE 4TH FLOOR ARLINGTON VA 22202 042679824 501(C)(3) 2756683 0 PARTNER SUPPORT KARNA LLC 2800 CENTURY PKWY NE SUITE 700 ATLANTA GA 30345 263002962 491086 0 PARTNER SUPPORT KATI COLLECTIVE INC 13346 108TH AVENUE SW VASHON WA 98070 843168072 271013 0 PARTNER SUPPORT MASSACHUSETTS INSTITUTE OF TECHNOLOGY 77 MASSACHUSETTS AVENUE CAMBRIDGE MA 021394307 042103594 501(C)(3) 43000 0 PARTNER SUPPORT MASTERCARD INTERNATIONAL INC 200 PURCHASE STREET PURCHASE NEW YORK NY 10577 952536378 486474 0 PARTNER SUPPORT NEXLEAF ANALYTICS 1964 WESTWOOD BOULEVARD LOS ANGELES CA 90025 900514027 501(C)(3) 1173510 0 PARTNER SUPPORT PAN AMERICAN SANITARY BUREAU 525 TWENTY-THIRD STEET NW WASHINGTON DC 20037 521804954 PASB 949130 0 PARTNER SUPPORT PARSYL INC 2714 WALNUT STREET DENVER CO 80205 814027966 1500000 0 PARTNER SUPPORT PATH 2201 WESTLAKE AVENUE SEATTLE WA 98109 911157127 501(C)(3) 1492772 0 PARTNER SUPPORT PREMISE DATA CORPORATION 185 BERRY STREET SUITE 6850 SAN FRANCISCO CA 94107 455294131 497690 0 PARTNER SUPPORT RESULTS FOR DEVELOPMENT INSTITUTE 1111 19TH STREET NW SUITE 700 WASHINGTON DC 20036 208530747 501(C)(3) 924579 0 PARTNER SUPPORT THE DIFFERENCE A2C LLC 661 AUBURN AVENUE NE SUITE 5 ATLANTA GA 30312 261133788 73350 0 PARTNER SUPPORT THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 WEST 131ST STREET NEW YORK NY 10027 135598093 501(C)(3) 216176 0 PARTNER SUPPORT THE WORLD BANK (IBRD) 1818 H STREET WASHINGTON DC 20433 980002549 THE WORLD BANK 7995281 0 PARTNER SUPPORT UNICEF 333 EAST 38TH STREET NEW YORK NY 10116 131760110 501(C)(3) 69119794 0 PROCUREMENT FEE & PARTNER SUPPORT UNIVERSITY OF WASHINGTON 1400 NE CAMPUS PARKWAY SEATTLE WA 98195 916001537 STATE OF WA 200000 0 PARTNER SUPPORT VILLAGE REACH 2900 EASTLAKE AVE E SUITE 230 SEATTLE WA 98102 912083484 501(C)(3) 1087137 0 PARTNER SUPPORT YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 06508 060646973 501(C)(3) 102010 0 PARTNER SUPPORT ZENYSIS TECHNOLOGIES INC 2325 3RD ST NUMBER 213 SAN FRANCISCO CA 94107 810929294 1044101 0 PARTNER SUPPORT ZIPLINE INTERNATIONAL INC 495 PINE AVE HALF MOON BAY CA 94019 453197601 450000 0 PARTNER SUPPORT 20 9 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND SUBSEQUENTLY DISBURSED IN GAVI PROGRAMME COUNTRIES AS DESCRIBED IN SCHEDULE F, PART V. ANY GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND USED INSIDE THE US ARE MONITORED THROUGH THE FOLLOWING WAYS: (I) THROUGH, AT MINIMUM, ANNUAL TECHNICAL PROGRESS REPORTS AND CERTIFIED FINANCIAL REPORTS FROM GRANTEES THAT SUPPORT THE ACHIEVEMENT OF MILESTONES STIPULATED IN THE GRANT AGREEMENTS. REPORTS ARE RECEIVED AND REVIEWED BY THE GAVI STAFF BUSINESS OWNER; AND (II) ARE SUBJECT TO GAVI INTERNAL AUDIT AS APPROPRIATE. X X 1 1 X X X 0 0 0 0 0 0 0 0 0 DR SETH BERKLEY CHIEF EXECUTIVE OFFICER 419544 0 16480 0 288427 0 94545 0 20465 0 839461 0 0 0 ANURADHA GUPTA DEPUTY CHIEF EXECUTIVE OFFICER - UNTIL 09/22 235510 0 16367 0 61770 0 53072 0 9156 0 375875 0 0 0 HANNAH BURRIS CHIEF OF STAFF 186469 0 3508 0 130449 0 39400 0 14093 0 373919 0 0 0 PASCAL BAROLLIER MANAGING DIR, PUBLIC ENGAGEMENT & IS 258779 0 5132 0 0 0 58154 0 25944 0 348009 0 0 0 MARIE-ANGE SARAKA-YAO MNG DIR, RESOURCE MOBL./PARTNERSHIPS 265185 0 10502 0 0 0 59760 0 5189 0 340636 0 0 0 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 219192 0 4346 0 50796 0 47879 0 14093 0 336306 0 0 0 ANDREW MENDS DIRECTOR OPERATIONS 217992 0 4326 0 50796 0 47553 0 14093 0 334760 0 0 0 PAOLO SISON DIRECTOR INNOVATIVE FINANCE 245988 0 17219 0 1328 0 39481 0 25420 0 329436 0 0 0 JEANNE SHEN CHIEF INVESTMENT OFFICER 241500 0 16905 0 1304 0 38761 0 17306 0 315776 0 0 0 BRENDA KILLEN DIRECTOR, GOVERNANCE 198519 0 7679 0 50796 0 42483 0 14093 0 313570 0 0 0 THABANI MAPHOSA MANAGING DIR, COUNTRY PROGRAMMES 216385 0 4291 0 25398 0 47106 0 17732 0 310912 0 0 0 AURELIA NGUYEN MNG DIR OFFICE OF THE COVAX FACILITY - UNTIL 07/22 229786 0 10335 0 0 0 51783 0 7842 0 299746 0 0 0 ASSIETOU DIOUF CHIEF FINANCIAL OFFICER 224654 0 4455 0 0 0 49308 0 20323 0 298740 0 0 0 DERRICK SIM ACTING MD OFFICE OF COVAX FACILITY - FROM 07/22 204248 0 3773 0 0 0 42823 0 21385 0 272229 0 0 0 DAVID MARLOW CHIEF OPERATING OFFICER - FROM 07/22 125268 0 0 0 39080 0 28071 0 8881 0 201300 0 0 0 PART I, LINE 1A UNDER AN AGREEMENT WITH THE SWISS GOVERNMENT, NON-SWISS EMPLOYEES OF THE GAVI ALLIANCE WORKING IN GENEVA, SWITZERLAND ARE EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. AS THE GAVI ALLIANCE IN GENEVA OPERATES AN INTERNAL TAX SCHEME, EMPLOYEES OF SWISS NATIONALITY ARE ALSO EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. TO ENSURE EQUITY AMONGST GAVI EMPLOYEES, CERTAIN ELIGIBLE EMPLOYEES WHO HAVE A FOREIGN TAX LIABILITY ON THEIR GAVI SALARY AND ALLOWANCES (E.G. US NATIONALS AND EMPLOYEES LIVING IN FRANCE) MAY RECEIVE ASSISTANCE FROM GAVI IN MEETING THEIR TAX OBLIGATIONS IN ACCORDANCE WITH GAVI'S FOREIGN TAX POLICY. IN ADDITION, FOR THE YEAR ENDED DECEMBER 31, 2022, THE CHIEF EXECUTIVE OFFICER RECEIVED A HOUSING ALLOWANCE OF CHF-18,000 WHICH WAS TREATED AS TAXABLE COMPENSATION. SCHEDULE J, PART II, COLUMN (B)(III): OTHER REPORTABLE COMPENSATION - THIS INCLUDES ALLOWANCES DUE TO EMPLOYEES UNDER GAVI'S HR POLICY, INCLUDING ALLOWANCES FOR RELOCATION, EDUCATION GRANT AND REIMBURSEMENT OF NON-SWISS TAXES ON GAVI INCOME. SCHEDULE J, PART II: GAVI REPORTED COMPENSATION ALL VALUES IN SWISS FRANCS (CHF) A B C D E F G BONUS OTHER REPORTED COMP RETIRE NONTAX BASE AND TAX EDU MENT ABLE COMP INC REIMB GRANT BENEFITS PLAN HEALTH INS DR. SETH BERKLEY 2021 392,567 3,887 174,293 48,400 18,000 88,466 19,460 2022 399,756 15,702 208,423 48,400 18,000 90,086 19,500 BRENDA KILLEN 2021 187,489 1,085 0 48,400 0 40,078 13,384 2022 189,156 7,317 0 48,400 0 40,479 13,428 ASSIETOU DIOUF 2021 212,237 2,102 0 0 0 46,518 19,712 2022 214,058 4,245 0 0 0 46,982 19,364 ANURADHA GUPTA 2021 311,909 6,238 0 0 0 70,289 10,521 2022 224,402 15,595 0 0 58,856 50,569 8,724 THABANI MAPHOSA 2021 204,425 2,024 0 24,200 0 44,440 16,856 2022 206,180 4,088 0 24,200 0 44,884 16,896 PASCAL BAROLLIER 2021 244,479 2,421 0 0 0 54,862 24,640 2022 246,573 4,890 0 0 0 55,411 24,720 MARIE-ANGE SARAKA-YAO 2021 250,173 2,477 0 0 0 56,377 4,928 2022 252,677 10,007 0 0 0 56,941 4,944 AURELIA NGUYEN 2021 246,886 2,437 0 0 0 55,478 8,456 2022 218,948 9,848 0 0 0 49,341 7,472 EDMUND GROVE 2021 207,076 2,050 0 48,400 0 45,170 13,384 2022 208,854 4,141 0 48,400 0 45,621 13,428 ANDREW MENDS 2021 206,079 2,040 0 48,400 0 44,861 13,384 2022 207,710 4,122 0 48,400 0 45,310 13,428 DAVID MARLOW 2022 119,360 0 8,903 0 28,334 26,747 8,462 DERRICK SIM 2022 194,615 3,595 0 0 0 40,803 20,376 HANNAH BURRIS 2022 177,674 3,343 51,696 72,600 0 37,542 13,428 PAOLO SISON AND JEANNE SHEN ARE WASHINGTON, DC BASED EMPLOYEES AND THEREFORE REPORTED COMPENSATION ARE ONLY IN UNITED STATES DOLLAR. THE CHF-USD EXCHANGE RATE IS 1.0931 IN 2021 AND 1.0495 IN 2022 THE FULL TEXT OF THE ABBREVIATED HEADINGS IN THE TABLE ABOVE ARE AS FOLLOWS: A - BASE COMPENSATION B - BONUS AND INCENTIVE "OTHER REPORTED COMPENSATION" INCLUDES THE FOLLOWING: C - US TAX REIMBURSEMENT D - EDUCATION GRANT E - OTHER BENEFITS F - RETIREMENT PLAN G - NON-TAXABLE HEALTH INSURANCE SCHEDULE J, PART III: THREE OF GAVI ALLIANCE'S HIGHEST COMPENSATED EMPLOYEES ARE BASED IN GENEVA, SWITZERLAND. THESE EMPLOYEES' SALARIES REFLECTED THE COST OF LIVING IN GENEVA AND INCLUDE BENEFITS SUCH AS EDUCATION GRANT AND US TAX REIMBURSEMENT. THE BENEFITS PROVIDED TO EMPLOYEES ARE COMPARABLE TO THOSE PROVIDED BY OTHER INTERNATIONAL NOT-FOR-PROFIT ORGANISATIONS. ALL THREE HAVE EDUCATION GRANT AND ONLY ONE HAS US TAX REIMBURSEMENT. TWO OF GAVI ALLIANCE'S HIGHEST COMPENSATED EMPLOYEES ARE BASED IN WASHINGTON, DC. THESE EMPLOYEES ARE INCLUDED THIS YEAR DUE TO THE STRENGTHENING OF THE UNITED STATES DOLLAR (I.E. SALARIES IN SWISS FRANCS CONVERTED TO UNITED STATES DOLLAR IS 4% LOWER THAN IN 2021) AND TO A HIGHER PERFORMANCE REWARD SCHEME IN 2022 IN THE WASHINGTON, DC OFFICE IN COMPARISON TO GENEVA DUE TO MARKET CONDITIONS. X 196012508 1308272506 FMV 0 1 0 PART I, COLUMN (B): GAVI REPORTS THE NUMBER OF DOSES IN COLUMN (B). FORM 990, BOX 5: GAVI IS AN INDEPENDENT NON-PROFIT FOUNDATION WITHIN THE MEANING OF ARTICLES 80 ET SEQ. OF THE SWISS CIVIL CODE. IT IS REGISTERED AT THE REGISTRY OF COMMERCE OF THE CANTON OF GENEVA AND PLACED UNDER THE SUPERVISION OF THE SWISS SUPERVISORY BOARD FOR FOUNDATIONS. FORM 990, PART I, LINE 5: PART I, LINE 5 LISTS THE TOTAL NUMBER OF EMPLOYEES BASED IN WASHINGTON, DC AND WHO RECEIVED THE FORM W-2. IT DOES NOT INCLUDE FOREIGN AND US CITIZEN EMPLOYEES BASED IN GENEVA, SWITZERLAND. THE TOTAL NUMBER OF EMPLOYEES, INCLUDING US CITIZEN EMPLOYEES BASED IN GENEVA AND WASHINGTON, DC, IS 375. FORM 990, PART VI, SECTION A, LINE 4 THE GAVI ALLIANCE BOARD AMENDED SECTION 25.1 OF THE BOARD AND BOARD COMMITTEE OPERATING PROCEDURES TO READ AS FOLLOWS: APPOINTMENT AND TERM: THE CEO SHALL BE SELECTED BY THE BOARD BASED ON MERIT, IN A NON-POLITICAL, OPEN AND COMPETITIVE MANNER. THE CEO SHALL BE APPOINTED TO RENEWABLE TERMS OF THREE YEARS. FORM 990, PART VI, SECTION B, LINE 11B THE OUTSOURCED ACCOUNTANT (OA), IN COLLABORATION WITH THE SENIOR MANAGER OF FINANCIAL REPORTING, GATHERS ALL INFORMATION NEEDED TO PREPARE THE FEDERAL FORM 990 FROM THE RESPECTIVE GAVI DEPARTMENTS. OA THEN PREPARES THE DRAFT FEDERAL FORM 990 AND PROVIDES IT TO THE GAVI HEAD OF FINANCIAL REPORTING, ACCOUNTING AND CONTROLLING (HFRAC) FOR REVIEW. THE HFRAC REVIEWS THE DRAFT FEDERAL FORM 990 AND DISCUSSES ANY NECESSARY CHANGES WITH THE OA AND SENIOR MANAGER. THE OA THEN SUBMITS THE DRAFT FEDERAL FORM 990 TO THE TAX FIRM FOR REVIEW AND DISCUSSES ANY NECESSARY UPDATES PROVIDED BY THE TAX FIRM, AFTER WHICH THE DRAFT FEDERAL FORM 990 IS UPDATED BY THE OA. THE SENIOR MANAGER THEN CIRCULATES THE UPDATED DRAFT FEDERAL FORM 990 TO VARIOUS GAVI TEAMS FOR THEIR REVIEW AND COMMENT. THE DRAFT FEDERAL FORM 990 IS UPDATED FOR COMMENTS RECEIVED AS DEEMED NECESSARY BY THE HFRAC. THE DRAFT FEDERAL FORM 990, INCLUDING ALL REQUIRED SCHEDULES, IS PROVIDED TO THE AUDIT AND FINANCE COMMITTEE. A GAVI AUTHORIZED REPRESENTATIVE SIGNS THE FEDERAL FORM 990 AFTER WHICH IT IS FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE GOVERNANCE TEAM CIRCULATES THE CONFLICT OF INTEREST DISCLOSURE FORMS TO THE BOARD MEMBERS ANNUALLY. GOVERNANCE MONITORS DISCLOSURE FORMS BY COLLECTING ALL CONFLICT OF INTEREST DISCLOSURES FROM BOARD MEMBERS. THE POLICY IS MONITORED BY THE BOARD OF DIRECTORS ITSELF, AND RELEVANT CONFLICTS ARE DISCLOSED AT THE BOARD OF DIRECTORS MEETINGS AND NOTED IN THE MINUTES. DECLARATIONS OF INTERESTS OF PARTICIPATING BOARD AND COMMITTEE MEMBERS ARE ALSO SHARED AS PART OF THE ADVANCE MATERIAL FOR EACH MEETING. A BOARD MEMBER/ALTERNATE BOARD MEMBER OR COMMITTEE DELEGATE IS EXPECTED TO DISCLOSE ANY REAL/PERCEIVED OR POTENTIAL CONFLICT TO THE CHAIR OF THE BOARD OR THE COMMITTEE, AS SOON AS POSSIBLE UPON LEARNING OF IT AND NO LATER THAN AT THE BEGINNING OF THE DISCUSSION OF THE PERTINENT AGENDA ITEM DURING A BOARD/COMMITTEE MEETING. IT IS THE PREROGATIVE OF THE CHAIR OF THE MEETING, IN CONSULTATION WITH THE DIRECTOR OF GOVERNANCE, TO DETERMINE THE SCOPE AND LEVEL OF A CONFLICTED PERSON'S PARTICIPATION IN THE DISCUSSION AND THE NECESSITY OF RECUSAL FROM VOTING GIVEN THE TYPE OF INTEREST DISCLOSED. RECUSALS AND/OR ABSTENTIONS FROM ANY DISCUSSIONS AND VOTES ARE NOTED IN THE MINUTES OF THE RELEVANT MEETING. FORM 990, PART VI, SECTION B, LINE 15 GAVI'S COMPENSATION AIMS TO ATTRACT, ENGAGE, REWARD AND RETAIN A TEAM OF HIGH PERFORMING EMPLOYEES WHO ARE DEDICATED TO GAVI'S MISSION. A SYSTEMATIC PROCESS IS SET FOR THE DETERMINATION OF STARTING SALARIES FOR STAFF AT GAVI. KEY CRITERIA FOR ALL KEY POSITIONS AND OFFICERS INCLUDE THE ASSESSMENT AND SUITABILITY OF THE CANDIDATE AGAINST THE ROLE AND THE INTERNAL EQUITY OF THEIR BREADTH AND DEPTH OF EXPERIENCE AS IT RELATED TO THEIR PEERS. FOUR KEY INDIVIDUALS ARE INVOLVED IN THE DELIBERATION AND DECISION OF THE SALARY, WHICH NORMALLY INCLUDES THE RECRUITER, THE HR DIRECTOR AND THE CEO AND DEPUTY CEO (NOW THE COO). THE EMPHASIS ON INTERNAL EQUITY WAS A DRIVER FOR GAVI TO BE CERTIFIED IN 2018 AS THE FIRST INTERNATIONAL GLOBAL HEALTH ORGANIZATION IN SWITZERLAND TO PAY EQUALLY MEN AND WOMEN STAFF, AFTER A RIGOROUS EXTERNAL AUDIT PROCESS WITH THE EQUAL SALARY FOUNDATION. GAVI CONTINUES TO BE CERTIFIED AS AN EQUAL SALARY EMPLOYER EVERY YEAR SINCE. FORM 990, PART VI, SECTION C, LINE 19 GOVERNANCE DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE POSTED ON THE GAVI ALLIANCE WEBSITE. FORM 1023 AND FEDERAL FORM 990 ARE MADE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. FORM 990, PART VII, SECTION A: AN ALTERNATE MEMBER CAN VOTE ONLY WHEN THE CORRESPONDING PRIMARY BOARD MEMBER IS UNABLE TO PARTICIPATE IN VOTING. IF THE PRIMARY BOARD MEMBER IS ABLE TO SUBMIT HIS/HER VOTE THEN THE ALTERNATE MEMBER'S VOTE IS NOT REQUIRED. PART VII LISTS 45 VOTING BOARD MEMBERS. HOWEVER ONLY 26 VOTES COULD BE CAST WHICH ARE PRINCIPAL BOARD MEMBERS. THE 19 ALTERNATE BOARD MEMBERS COULD NOT VOTE UNLESS THEIR ASSOCIATED PRINCIPAL BOARD MEMBER WAS UNAVAILABLE TO VOTE. NONE OF THE ALTERNATE BOARD MEMBER SEATS WERE VACANT. FORM 990, PART XI, LINE 9: RETURN OF UNSPENT FUNDS 1,621,786. RECOVERY OF PRIOR YEAR GRANT 113,214,483. INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY CARPENTER COURT 1 MAPLE ROAD BRAM STOCKPORT CHESHIRE UK SK7 2DH RAISES FUNDS FOR IMMUNIZATION PROGRAMS AND PROCUREMENT UK 501(C)(3) FOREIGN CHARITY GAVI ALLIANCE 1 IFFIM SUKUK COMPANY III LIMITED PO BOX 1093 QUEENSGATE HOUSE GRAND CAYMAN CJ KY1-1102 ISSUING SUKUK CERTIFICATES IN SUPPORT OF IFFIM'S OPERATIONS CJ INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY C 490000000 COST INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY N 180261 FMV INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY O 805389 FMV